Industry guidelines, laws and regulations ignored: Quality of drug advertising in medical journals

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 11, 2004, Pages 789-795

  Lankinen, Kari S ^a,d   Levola, Tero ^b   Marttinen, Kati ^c   Puumalainen, Inka ^a   Helin Salmivaara, Arja ^a  

^a Finska Lo karforeningen Duodecim   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NONE   (Finland)

Author keywords

Advertising; Ethics; Marketing; Medical journals

Indexed keywords

ARTICLE; CLASSIFICATION; CONTROLLED STUDY; DRUG CONTROL; DRUG INDUSTRY; DRUG MARKETING; DRUG MONITORING; EMOTION; EVIDENCE BASED MEDICINE; FINLAND; HUMAN; LAW; MEDICAL LITERATURE; MEDLINE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; PUNISHMENT; QUALITY CONTROL; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADVERTISING; DRUG INDUSTRY; FINLAND; HUMANS; PERIODICALS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY CONTROL;

EID: 8644250764     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1017     Document Type: Article

References (19)

1. Anonymous. Can the advertisements in a reputable medical journal promote quackery? JAMA 1894; 22: 958.
2. Herxheimer A, Lundborg CS, Westerholm B. Advertisements for medicines in leading medical journals in 18 countries: a 12-month survey of information content and standards. Int J Health Serv 1993; 23 1): 161-172.
3. Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 2001; 14(3): 197-200.
4. Vlassov V, Mansfield P, Lexchin J, Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med 2001; 174(6): 391-394.
5. Loke TW, Koh FC, Ward JE. Pharmaceutical advertisements in Australian medical publications. Med J Australia 2002; 177: 291-293.
6. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992; 116(11): 912-919.
7. Lexchin J, Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Can Med Assoc J 1994; 151(1): 47-54.
8. IFPMA. IFPMA Code of Pharmaceutical Marketing Practices International Federation of Pharmaceutical Manufacturers Associations: Geneva, 1994.
9. WHO. Ethical Criteria for Medicinal Drug Promotion. World Health Organization: Geneva, 1998.
10. European Commission. Notice to Applicants. A Guideline on Summary of Product Characteristics. The Rules Governing Medicinal Products in the European Community. European Commission: Brussels, 1999; 19.
11. PIF. The Finnish Code for the Marketing of Medicinal Products. Pharma Industry Finland: Helsinki, 2001.
12. Villanueva P, Peiró S, Librero J, Pereiró I. Accuracy of pharmaceutical advertisements in medical journals. Lancet 2003; 361(Jan 4): 27-32.
13. Wang TJ, Ausiello JC, Stafford RS. Trends in antihypertensive drug advertising, 1985-1996. Circulation 1999; 99: 2055-2057.
14. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982; 73(1): 4-8.
15. Christo GO, Balasubramaniam R. Commentary: advertising adversities. Br Med J 1997; 315: 460.
16. Fletcher RH, Fletcher SW. Pharmaceutical advertisements in medical journals. Ann Intern Med 1992; 116(11): 951-952.
17. Beaty JF. Pharmaceutical ads in journals (letter). Ann Intern Med 1992; 117(7): 616.
18. Kessler DA. Addressing the problem of misleading advertising. Ann Intern Med 1992; 116(11): 950-951.
19. Helin-Salmivaara A, Puumalainen I, Marttinen K, Levola T, Lankinen KS. How strong is the evidence? Marketing claims and use of references in drug advertising (In Finnish: Miten vahva on nä yttö? Lääkemainosten markkinointiväittämät ja niiden viitteet). Suomen Lääkärilehti 2003; 58(15): 1786-1791.